Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase I/II study of a recombinant tetanus vaccine in healthy Chinese adults
ChiCTR1800015865Phase 2Recruiting
- Sponsor
- First Affiliated Hospital, Zhejiang University School of Medicine
- Start
- May 2018
- Modality
- Split/Subunit Vaccines → Inactivated Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics, Recombinant Protein Vaccines → Recombinant Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of recombinant tetanus vaccine in Tetanus (5 arms), sponsored by First Affiliated Hospital, Zhejiang University School of Medicine. Primary endpoint: Incidence of adverse reactions. Started May 2018; status: recruiting.
02
Drugs
recombinant tetanus vaccine
03
Conditions
Tetanus
Beyond the preview
Go deeper on ChiCTR1800015865.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1800015865.